Logo image of CI

THE CIGNA GROUP (CI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CI - US1255231003 - Common Stock

274.91 USD
+3.67 (+1.35%)
Last: 1/21/2026, 8:04:00 PM
274.91 USD
0 (0%)
After Hours: 1/21/2026, 8:04:00 PM
Fundamental Rating

5

CI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CI while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on CI. CI also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CI had positive earnings in the past year.
  • In the past year CI had a positive cash flow from operations.
  • CI had positive earnings in each of the past 5 years.
  • CI had a positive operating cash flow in each of the past 5 years.
CI Yearly Net Income VS EBIT VS OCF VS FCFCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • CI's Return On Assets of 3.89% is fine compared to the rest of the industry. CI outperforms 69.61% of its industry peers.
  • CI's Return On Equity of 14.70% is amongst the best of the industry. CI outperforms 80.39% of its industry peers.
  • With a decent Return On Invested Capital value of 8.31%, CI is doing good in the industry, outperforming 74.51% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CI is in line with the industry average of 9.21%.
  • The 3 year average ROIC (7.53%) for CI is below the current ROIC(8.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.89%
ROE 14.7%
ROIC 8.31%
ROA(3y)3.41%
ROA(5y)3.82%
ROE(3y)11.49%
ROE(5y)12.53%
ROIC(3y)7.53%
ROIC(5y)6.93%
CI Yearly ROA, ROE, ROICCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • CI has a better Profit Margin (2.29%) than 62.75% of its industry peers.
  • In the last couple of years the Profit Margin of CI has declined.
  • CI has a Operating Margin (3.72%) which is comparable to the rest of the industry.
  • CI's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 9.55%, CI is doing worse than 74.51% of the companies in the same industry.
  • CI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.72%
PM (TTM) 2.29%
GM 9.55%
OM growth 3Y-6.1%
OM growth 5Y-7.49%
PM growth 3Y-23.32%
PM growth 5Y-16%
GM growth 3Y-7.3%
GM growth 5Y-8.44%
CI Yearly Profit, Operating, Gross MarginsCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CI is destroying value.
  • Compared to 1 year ago, CI has less shares outstanding
  • Compared to 5 years ago, CI has less shares outstanding
  • The debt/assets ratio for CI is higher compared to a year ago.
CI Yearly Shares OutstandingCI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CI Yearly Total Debt VS Total AssetsCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 2.63 indicates that CI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CI (2.63) is comparable to the rest of the industry.
  • CI has a debt to FCF ratio of 4.58. This is a neutral value as CI would need 4.58 years to pay back of all of its debts.
  • CI has a better Debt to FCF ratio (4.58) than 68.63% of its industry peers.
  • A Debt/Equity ratio of 0.74 indicates that CI is somewhat dependend on debt financing.
  • CI's Debt to Equity ratio of 0.74 is in line compared to the rest of the industry. CI outperforms 50.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 4.58
Altman-Z 2.63
ROIC/WACC0.97
WACC8.54%
CI Yearly LT Debt VS Equity VS FCFCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that CI may have some problems paying its short term obligations.
  • With a Current ratio value of 0.83, CI is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.73 indicates that CI may have some problems paying its short term obligations.
  • CI has a worse Quick ratio (0.73) than 78.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.73
CI Yearly Current Assets VS Current LiabilitesCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 3.35% over the past year.
  • The Earnings Per Share has been growing by 10.05% on average over the past years. This is quite good.
  • Looking at the last year, CI shows a quite strong growth in Revenue. The Revenue has grown by 15.26% in the last year.
  • The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)3.35%
EPS 3Y10.13%
EPS 5Y10.05%
EPS Q2Q%4.26%
Revenue 1Y (TTM)15.26%
Revenue growth 3Y12.39%
Revenue growth 5Y9.98%
Sales Q2Q%9.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.86% on average over the next years. This is quite good.
  • CI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.58% yearly.
EPS Next Y11.67%
EPS Next 2Y7.03%
EPS Next 3Y8.01%
EPS Next 5Y8.86%
Revenue Next Year11.03%
Revenue Next 2Y7.79%
Revenue Next 3Y7.23%
Revenue Next 5Y5.58%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CI Yearly Revenue VS EstimatesCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B
CI Yearly EPS VS EstimatesCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.68, the valuation of CI can be described as very reasonable.
  • 94.12% of the companies in the same industry are more expensive than CI, based on the Price/Earnings ratio.
  • CI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.32.
  • A Price/Forward Earnings ratio of 8.78 indicates a reasonable valuation of CI.
  • 93.14% of the companies in the same industry are more expensive than CI, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CI to the average of the S&P500 Index (24.30), we can say CI is valued rather cheaply.
Industry RankSector Rank
PE 9.68
Fwd PE 8.78
CI Price Earnings VS Forward Price EarningsCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CI is valued cheaper than 80.39% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CI is valued cheaper than 86.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.87
EV/EBITDA 7.87
CI Per share dataCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.83
PEG (5Y)0.96
EPS Next 2Y7.03%
EPS Next 3Y8.01%

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.17%, CI has a reasonable but not impressive dividend return.
  • CI's Dividend Yield is rather good when compared to the industry average which is at 0.59. CI pays more dividend than 94.12% of the companies in the same industry.
  • CI's Dividend Yield is comparable with the S&P500 average which is at 1.86.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • On average, the dividend of CI grows each year by 169.26%, which is quite nice.
  • CI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)169.26%
Div Incr Years4
Div Non Decr Years19
CI Yearly Dividends per shareCI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • 26.01% of the earnings are spent on dividend by CI. This is a low number and sustainable payout ratio.
  • CI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP26.01%
EPS Next 2Y7.03%
EPS Next 3Y8.01%
CI Yearly Income VS Free CF VS DividendCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
CI Dividend Payout.CI Dividend Payout, showing the Payout Ratio.CI Dividend Payout.PayoutRetained Earnings

THE CIGNA GROUP

NYSE:CI (1/21/2026, 8:04:00 PM)

After market: 274.91 0 (0%)

274.91

+3.67 (+1.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-05
Inst Owners90.65%
Inst Owner Change0.06%
Ins Owners0.33%
Ins Owner Change-0.04%
Market Cap73.44B
Revenue(TTM)268.08B
Net Income(TTM)6.15B
Analysts82.42
Price Target333.39 (21.27%)
Short Float %1.79%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend5.53
Dividend Growth(5Y)169.26%
DP26.01%
Div Incr Years4
Div Non Decr Years19
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.44%
Min EPS beat(2)-2.29%
Max EPS beat(2)-0.6%
EPS beat(4)1
Avg EPS beat(4)-4.36%
Min EPS beat(4)-17.61%
Max EPS beat(4)3.05%
EPS beat(8)5
Avg EPS beat(8)-1.57%
EPS beat(12)6
Avg EPS beat(12)-1.3%
EPS beat(16)9
Avg EPS beat(16)0.51%
Revenue beat(2)2
Avg Revenue beat(2)2.66%
Min Revenue beat(2)0.9%
Max Revenue beat(2)4.42%
Revenue beat(4)4
Avg Revenue beat(4)2.81%
Min Revenue beat(4)0.59%
Max Revenue beat(4)5.31%
Revenue beat(8)7
Avg Revenue beat(8)2%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)8
Avg Revenue beat(16)0.46%
PT rev (1m)-0.67%
PT rev (3m)-9.58%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-2.46%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.59%
Valuation
Industry RankSector Rank
PE 9.68
Fwd PE 8.78
P/S 0.27
P/FCF 9.87
P/OCF 8.48
P/B 1.76
P/tB N/A
EV/EBITDA 7.87
EPS(TTM)28.41
EY10.33%
EPS(NY)31.32
Fwd EY11.39%
FCF(TTM)27.84
FCFY10.13%
OCF(TTM)32.43
OCFY11.8%
SpS1003.55
BVpS156.5
TBVpS-120.14
PEG (NY)0.83
PEG (5Y)0.96
Graham Number316.29
Profitability
Industry RankSector Rank
ROA 3.89%
ROE 14.7%
ROCE 9.83%
ROIC 8.31%
ROICexc 8.92%
ROICexgc 40.82%
OM 3.72%
PM (TTM) 2.29%
GM 9.55%
FCFM 2.77%
ROA(3y)3.41%
ROA(5y)3.82%
ROE(3y)11.49%
ROE(5y)12.53%
ROIC(3y)7.53%
ROIC(5y)6.93%
ROICexc(3y)8.17%
ROICexc(5y)7.51%
ROICexgc(3y)41.92%
ROICexgc(5y)35.13%
ROCE(3y)8.97%
ROCE(5y)8.27%
ROICexgc growth 3Y24.32%
ROICexgc growth 5Y14.18%
ROICexc growth 3Y11.69%
ROICexc growth 5Y5.98%
OM growth 3Y-6.1%
OM growth 5Y-7.49%
PM growth 3Y-23.32%
PM growth 5Y-16%
GM growth 3Y-7.3%
GM growth 5Y-8.44%
F-Score6
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 4.58
Debt/EBITDA 2.44
Cap/Depr 45.46%
Cap/Sales 0.46%
Interest Coverage 7.4
Cash Conversion 68.38%
Profit Quality 120.99%
Current Ratio 0.83
Quick Ratio 0.73
Altman-Z 2.63
F-Score6
WACC8.54%
ROIC/WACC0.97
Cap/Depr(3y)48.86%
Cap/Depr(5y)45.02%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.69%
Profit Quality(3y)189.84%
Profit Quality(5y)158.3%
High Growth Momentum
Growth
EPS 1Y (TTM)3.35%
EPS 3Y10.13%
EPS 5Y10.05%
EPS Q2Q%4.26%
EPS Next Y11.67%
EPS Next 2Y7.03%
EPS Next 3Y8.01%
EPS Next 5Y8.86%
Revenue 1Y (TTM)15.26%
Revenue growth 3Y12.39%
Revenue growth 5Y9.98%
Sales Q2Q%9.5%
Revenue Next Year11.03%
Revenue Next 2Y7.79%
Revenue Next 3Y7.23%
Revenue Next 5Y5.58%
EBIT growth 1Y0.13%
EBIT growth 3Y5.54%
EBIT growth 5Y1.75%
EBIT Next Year22.59%
EBIT Next 3Y9.56%
EBIT Next 5Y5.28%
FCF growth 1Y-31.72%
FCF growth 3Y14.05%
FCF growth 5Y1.21%
OCF growth 1Y-30.38%
OCF growth 3Y12.95%
OCF growth 5Y1.79%

THE CIGNA GROUP / CI FAQ

What is the fundamental rating for CI stock?

ChartMill assigns a fundamental rating of 5 / 10 to CI.


What is the valuation status of THE CIGNA GROUP (CI) stock?

ChartMill assigns a valuation rating of 8 / 10 to THE CIGNA GROUP (CI). This can be considered as Undervalued.


How profitable is THE CIGNA GROUP (CI) stock?

THE CIGNA GROUP (CI) has a profitability rating of 6 / 10.


What is the financial health of THE CIGNA GROUP (CI) stock?

The financial health rating of THE CIGNA GROUP (CI) is 3 / 10.


Can you provide the expected EPS growth for CI stock?

The Earnings per Share (EPS) of THE CIGNA GROUP (CI) is expected to grow by 11.67% in the next year.